Fasting glycemia screening is alternative to 75-g GTT for GDM

February 1, 2016

(HealthDay)—Screening for gestational diabetes with fasting glycemia seems to be an acceptable alternative to universal screening with the complete 75-gram glucose tolerance test, according to a study published online Jan. 25 in BJOG: An International Journal of Obstetrics & Gynaecology.

J. Ryser Rüetschi, from the University Hospitals of Geneva, and colleagues collected 2,298 complete 75-g glucose tolerance tests from pregnant women at 24 to 28 weeks of gestation. They simulated stopping the if fasting glycemia was <4.4 or ≥5.1 mmol/L, thereby avoiding glucose loading and further glycemia.

The researchers found that within the population, the prevalence of was 10.9 percent. Among 251 women with gestational diabetes, fasting glycemia was ≥5.1, between 4.4 and <5.1, and <4.4 mmol/L in 47.4, 31.1, and 21.5 percent, respectively. The sensitivity was 78.5 percent with performance of the complete test only in women with fasting glycemia between 4.4 and <5.1 mmol/L; this would avert glucose loading in 63.8 percent of women.

"Screening with fasting glycemia is an attractive alternative to with the complete 75-g glucose tolerance test," the authors write. "This strategy is, however, slightly less sensitive than previously reported in higher-risk populations."

Explore further: 4.4 mmol/L is optimal fasting glucose cutoff for GDM screening

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

4.4 mmol/L is optimal fasting glucose cutoff for GDM screening

April 16, 2013
(HealthDay)—A fasting plasma glucose value of 4.4 mmol/L is the optimal cut point for determining which pregnant Chinese women need a 75-g 2-h oral glucose tolerance test offered at 24 to 28 weeks' gestation, according ...

Sleep-disordered breathing in REM linked to insulin resistance

November 5, 2015
(HealthDay)—The correlation between sleep-disordered breathing (SDB) and glucose metabolism varies for rapid eye movement (REM) sleep and non-REM sleep, according to a study published in the Nov. 1 issue of the American ...

Maternal hyperglycemia not linked to obesity in offspring

June 29, 2015
(HealthDay)—Maternal hyperglycemia seems not to be a risk factor for obesity in offspring aged 5 to 7 years after adjustment for maternal body mass index (BMI), according to a study published online June 19 in Diabetes ...

Effect of maternal glycemia on childhood obesity and metabolic dysfunction

February 2, 2015
In a study to be presented on Feb. 5 in an oral concurrent session at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the impact of maternal glycemia ...

Hemoglobin A1C inadequate for postpartum diabetes screening

June 19, 2012
(HealthDay) -- For postpartum women who have had gestational diabetes mellitus (GDM), the hemoglobin A1c (A1C) test criteria alone or in combination with fasting glucose test criteria does not provide sensitive and specific ...

Plant hormone may play a vital role in blood sugar control and diabetes management

December 1, 2015
A treatment for managing blood sugar levels might be as close as the local health food store, suggests a new research report published in the December 2015 issue of The FASEB Journal. Specifically scientists from Italy have ...

Recommended for you

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

Millions of low-risk people with diabetes may be testing their blood sugar too often

December 10, 2018
For people with Type 2 diabetes, the task of testing their blood sugar with a fingertip prick and a drop of blood on a special strip of paper becomes part of everyday life.

Very low calorie diets trialled by NHS to tackle diabetes

December 7, 2018
Hundreds of thousands of people will receive NHS help to battle obesity and type 2 diabetes under radical action set out by Simon Stevens, Chief Executive of NHS England.

New therapeutic avenue for type 2 diabetes

December 6, 2018
Restoring the action of insulin is one of the keys to fighting type 2 diabetes. Researchers from Inserm led by Dominique Langin at the Institute of Cardiovascular and Metabolic Diseases (Inserm/Université de Toulouse) are ...

Subtype of immune B cells can delay type 1 diabetes onset in mice

December 6, 2018
A team of researchers at Baylor College of Medicine and the University of Michigan Medical School reports today in the JCI Insight that a subset of immune B cells, known as CD19+IgM+ B cells, can delay the onset of type 1 ...

Is the pancreas regeneration debate settled? An original theory renewed

December 5, 2018
A contentious debate among diabetes researchers has surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.